Amgen (AMGN) Acquisitions (2011 - 2022)

Amgen's Acquisitions history runs 10 years deep, the most recent figure standing at $3.8 billion for Q4 2022.

• In Q4 2022, Acquisitions rose 331.35% year-over-year to $3.8 billion; the TTM figure through Dec 2022 stood at $4.7 billion (up 425.14% YoY), while the FY2025 annual figure was $53.0 million, changed N/A from the prior year.
• Acquisitions was $3.8 billion for Q4 2022 at Amgen, up from $890.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $13.4 billion in Q4 2019 to a low of -$197.0 million in Q1 2018.
• Historically, Acquisitions has averaged $2.6 billion across 4 years, with a median of $177.0 million in 2019.
• The sharpest annual moves came in 2018 and 2019: Acquisitions slumped 89.47% in 2018, then surged 671900.0% in 2019.
• A 4-year view of Acquisitions shows it stood at $2.0 million in 2018, then soared by 671900.0% to $13.4 billion in 2019, then tumbled by 93.38% to $890.0 million in 2021, then surged by 331.35% to $3.8 billion in 2022.
• The last three Acquisitions figures came in at $3.8 billion (Q4 2022), $890.0 million (Q4 2021), and $13.0 million (Q3 2021), per Business Quant data.